ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,511,286 | -10.1% | 20,763,323 | +26.2% | 0.55% | -10.6% |
| Q2 2023 | $106,268,163 | +34.9% | 16,450,180 | +57.4% | 0.62% | +43.4% |
| Q1 2023 | $78,794,357 | -25.6% | 10,450,180 | 0.0% | 0.43% | -32.5% |
| Q4 2022 | $105,860,323 | +2.4% | 10,450,180 | 0.0% | 0.64% | -6.1% |
| Q3 2022 | $103,352,000 | -7.1% | 10,450,180 | 0.0% | 0.68% | +7.3% |
| Q2 2022 | $111,294,000 | +9.2% | 10,450,180 | 0.0% | 0.63% | +7.9% |
| Q1 2022 | $101,889,000 | -31.8% | 10,450,180 | 0.0% | 0.58% | -19.5% |
| Q4 2021 | $149,438,000 | -28.6% | 10,450,180 | 0.0% | 0.73% | -21.0% |
| Q3 2021 | $209,422,000 | -8.9% | 10,450,180 | 0.0% | 0.92% | -8.9% |
| Q2 2021 | $229,904,000 | -35.2% | 10,450,180 | 0.0% | 1.01% | -34.4% |
| Q1 2021 | $354,888,000 | -15.6% | 10,450,180 | 0.0% | 1.54% | -2.8% |
| Q4 2020 | $420,515,000 | – | 10,450,180 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |